Literature DB >> 3875651

Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells.

W E Weber, W A Buurman, M M Vandermeeren, J C Raus.   

Abstract

Monoclonal antibodies directed against CD3, a T cell-specific surface molecule essentially required for activation of these cells, are highly mitogenic for resting human peripheral blood T lymphocytes. A predetermined optimal concentration of anti-CD3 monoclonal antibody WT32 was employed to activate T cells cultured in limiting-dilution microcultures containing irradiated feeder cells and exogeneous interleukin 2. Frequencies of cells triggered into clonal expansion by WT32 under these culture conditions were 0.57 to 0.72 and 0.90 to 1.10 in peripheral blood mononuclear cells and E rosette-positive cells, respectively. It appeared that WT32 could induce virtually every human peripheral blood T lymphocyte to expand into a clonal progeny of 5 to 40 X 10(4) cells in 14 to 18 days of culture. This progeny was tested for cytolytic effector function with 51Cr-labeled murine P815 targets in the presence of PHA to detect all cytotoxic T lymphocytes (CTL) regardless of specificity, and was also assayed for natural killer like activity against K562 target cells. Frequencies of cells in the human peripheral blood T cell compartment giving rise to a clonal progeny expressing CTL function was 1/3, whereas 1/6 to 1/5 expanded into effector cell populations possessing NK activity. Frequency analysis of CD4-positive and CD8-positive populations, activated by WT32 in limiting dilution microcultures, demonstrated that 1 to 6% of the CD4-positive and 100% of the CD8-positive peripheral blood T lymphocytes expanded into CTL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875651

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Human T lymphocytes expressing a defined T-cell antigen receptor family specifically kill the hybridoma that makes the anti-receptor monoclonal antibody.

Authors:  A W Boylston; S J May
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

2.  Functional and phenotypical studies of the Leu-4 (CD3)+, Leu-1 (CD5)- T lymphocyte.

Authors:  E F Srour; E B Walker; D E Walker; J Jansen
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

3.  Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.

Authors:  R A Janssen; A A Heijn; T H The; L de Leij
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

4.  Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis.

Authors:  J M Van Laar; A M Miltenburg; M J Verdonk; M R Daha; R R De Vries; P J Van den Elsen; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

5.  Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype.

Authors:  D E Martin; L S Zalman; G Jung; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.

Authors:  P Höllsberg; W E Weber; F Dangond; V Batra; A Sette; D A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

7.  Detection of T cells responsive to a vascular growth factor in rheumatoid arthritis.

Authors:  V M Byrd; X M Zhao; G G Miller; J W Thomas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

8.  Clonal analysis of functionally distinct human CD4+ T cell subsets.

Authors:  F T Rotteveel; I Kokkelink; R A van Lier; B Kuenen; A Meager; F Miedema; C J Lucas
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

9.  The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity.

Authors:  B J Kroesen; G J Wellenberg; A Bakker; W Helfrich; T H The; L de Leij
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

10.  Regulation of T cell autocrine growth. T4+ cells become refractory to interleukin 2.

Authors:  M Gullberg; K A Smith
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.